Cambridge Cognition Holdings Plc (AIM: COG)

Market Cap	11.53M
Revenue (ttm)	13.08M
Net Income (ttm)	-1.32M
Shares Out	41.64M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	39.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51
Open	29.00
Previous Close	28.50
Day's Range	29.00 - 29.00
52-Week Range	26.40 - 60.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About COG

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides ...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 119
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: COG

Financial Performance

In 2023, COG's revenue was 13.52 million, an increase of 7.15% compared to the previous year's 12.61 million. Losses were -3.51 million, 757.7% more than in 2022.